Eric Martin
Managing Director, U.S. Central & Rocky Mtn Region / Canada, Business Development
Eric Martin
Managing Director, U.S. Central & Rocky Mtn Region / Canada, Business Development
Eric is the managing director of Business Development for the U.S. Central & Rocky Mountain Regions, and Canada. He works with deal parties, outside counsel and investors, providing education and guidance on SRS Acquiom's suite of products and services and how they can be used on transactions.
Before joining SRS Acquiom in 2012, Eric's career spanned several unique roles, including CFO for one of Colorado's oldest nonprofits, co-founder and partner in a contract packaging and fulfillment business, and corporate law practice at firms including Hogan Lovells, Arnold & Porter, and a few smaller firms in the Denver area.
Eric received a JD from the University of Denver School of Law, an MBA from the University of Colorado at Denver and a BS in Business from the University of Colorado at Boulder.
Eric frequently delivers presentations on M&A deal term trends, post-closing claim activity and SRS Acquiom’s technology platforms, often with CLE credit available. If interested, please reach out to schedule a virtual or in-person meeting.
How can we help?
SRS Acquiom provides a comprehensive suite of solutions for private target M&A and bilateral or syndicated loan transactions that can be utilized individually or in combination, customized for the needs of each transaction.
I am interested in
Learn moreFeatured Insights, Resources & Studies
Deal Terms Analysis
2024 M&A Deal Terms Study
Deal Terms Analysis
2024 M&A Claims Insights Report
Deal Terms Analysis
2024 M&A Working Capital PPA Study
Deal Terms Analysis
Life Sciences
2023 SRS Acquiom Life Sciences M&A Study
Shareholder Representation
Common Myths About Hiring a Professional Shareholder Representative
Loan Agency
Credit-Spread Adjustments and the State of SOFR Today
Deal Terms Analysis
2024 M&A Deal Terms Study
Deal Terms Analysis
2024 M&A Claims Insights Report
Deal Terms Analysis
2024 M&A Working Capital PPA Study
Deal Terms Analysis
Life Sciences
2023 SRS Acquiom Life Sciences M&A Study
Shareholder Representation
Common Myths About Hiring a Professional Shareholder Representative
Loan Agency
Credit-Spread Adjustments and the State of SOFR Today